JPS56103114A - Drug for osteoporosis comprising 24r- hydroxycholecalciferol - Google Patents

Drug for osteoporosis comprising 24r- hydroxycholecalciferol

Info

Publication number
JPS56103114A
JPS56103114A JP476480A JP476480A JPS56103114A JP S56103114 A JPS56103114 A JP S56103114A JP 476480 A JP476480 A JP 476480A JP 476480 A JP476480 A JP 476480A JP S56103114 A JPS56103114 A JP S56103114A
Authority
JP
Japan
Prior art keywords
bone
absorption
osteoporosis
drug
calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP476480A
Other languages
Japanese (ja)
Other versions
JPH0138771B2 (en
Inventor
Yuji Maeda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kureha Corp
Original Assignee
Kureha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Corp filed Critical Kureha Corp
Priority to JP476480A priority Critical patent/JPS56103114A/en
Publication of JPS56103114A publication Critical patent/JPS56103114A/en
Publication of JPH0138771B2 publication Critical patent/JPH0138771B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE: A drug for osteoporosis having improved bone-absorption inhibiting effects, comprising 24R-hydroxycholecalciferol.
CONSTITUTION: A drug for osteroporosis comprising 24R-hydroxychlolecalciferol shown by the formula as an active ingredient. Osteoporosis is a disease caused essentially by the increase in bone-absorption action (calcium is eluted from the bone to the blood) and the reduction in calcium absorption competence in intestine, bringing about fracture readily. The compound shown by the formula suppresses the secretion of parathyroid hormone (PTH) with bone absorption action for a long time, and has improved calcium absorption competence in intestine. It may be administered orally or parenterally. Its toxicity is extremely low.
COPYRIGHT: (C)1981,JPO&Japio
JP476480A 1980-01-18 1980-01-18 Drug for osteoporosis comprising 24r- hydroxycholecalciferol Granted JPS56103114A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP476480A JPS56103114A (en) 1980-01-18 1980-01-18 Drug for osteoporosis comprising 24r- hydroxycholecalciferol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP476480A JPS56103114A (en) 1980-01-18 1980-01-18 Drug for osteoporosis comprising 24r- hydroxycholecalciferol

Publications (2)

Publication Number Publication Date
JPS56103114A true JPS56103114A (en) 1981-08-18
JPH0138771B2 JPH0138771B2 (en) 1989-08-16

Family

ID=11592934

Family Applications (1)

Application Number Title Priority Date Filing Date
JP476480A Granted JPS56103114A (en) 1980-01-18 1980-01-18 Drug for osteoporosis comprising 24r- hydroxycholecalciferol

Country Status (1)

Country Link
JP (1) JPS56103114A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60120812A (en) * 1983-12-02 1985-06-28 Teijin Ltd Remedy for diabetic osteopenia

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0324265U (en) * 1989-07-19 1991-03-13

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5126859A (en) * 1974-08-22 1976-03-05 Teijin Ltd 24 * r * hidorokishikorekarushifuerooruno seizoho
JPS5326316A (en) * 1976-08-20 1978-03-11 Teijin Ltd Drug containing active vitamin d3 derivatives and its preparation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5126859A (en) * 1974-08-22 1976-03-05 Teijin Ltd 24 * r * hidorokishikorekarushifuerooruno seizoho
JPS5326316A (en) * 1976-08-20 1978-03-11 Teijin Ltd Drug containing active vitamin d3 derivatives and its preparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60120812A (en) * 1983-12-02 1985-06-28 Teijin Ltd Remedy for diabetic osteopenia

Also Published As

Publication number Publication date
JPH0138771B2 (en) 1989-08-16

Similar Documents

Publication Publication Date Title
MY130157A (en) Method of use for inhibiting bone loss and lowering serum cholesterol
ATE204178T1 (en) METHOD FOR TREATING AND PREVENTING TYPE 1 DIABETIS BY ORAL ADMINISTRATION OF INSULIN
CA2078019A1 (en) Substance or composition and uses thereof
JPS56103114A (en) Drug for osteoporosis comprising 24r- hydroxycholecalciferol
WO1990001321A3 (en) Method for treating and preventing loss of bone mass
JPS5630917A (en) Preventive and remedy for hepatitis
JPS542336A (en) Preventive and remedy for viral diseases
JPS57188520A (en) Antihyperkalemia
JPS5489036A (en) Remedy and preventive for hypersensitivity to light
RU98101105A (en) NEW APPLICATION FOR MEDICAL PURPOSES
JPS55122715A (en) Antidiabetic agent
JPS5675428A (en) Hypoglycemic agent containing procainamide hydrochloride
KR980700083A (en) Kit for Osteoporosis Treatment Cycle
JPS53127432A (en) Novel physiologically active substance, anthglutin, and its preparation
JPS5626819A (en) Preventive for hypoimmunity
JPS5420141A (en) Method and composition for preventing gastro-intestinal diseases of cattle
HU9302188D0 (en) Method for producing acylamino-alkylidene-hydroxi-biphosphonic acid derivatives as well as one for producing medical preparatives containing said compounds
KR910002455A (en) Pharmaceutical compositions containing acrylic acid derivatives and their use as medicaments
IL64839A (en) N-arylmethyl-4-(methylanilino)-5-sulfamoyl-anthranilic acids,a process for their preparation and pharmaceutical compositions containing them
JPS5634625A (en) Antitumorigenic agent
JPS53148537A (en) Prophylactic and remedy for acalcerosis of cattle and poultry
JPS5675427A (en) Antiarteriosclerotic agent containing procainamide hydrochloride
JPS54105237A (en) Analgesic agent containing nalorphine-6-glucuronide
JPS5742620A (en) Novel antiulcer agent
JPS552625A (en) Oral medicine for assisting liver function